A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3522-3527

  Tessitore, Alessandra ^a   Sinisi, Antonio A ^b   Pasquali, Daniela ^b   Cardone, Monica ^a   Vitale, Domenico ^a   Bellastella, Antonio ^b   Colantuoni, Vittorio ^a,c,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF SANNIO   (Italy)

^d Department of Biochemistry and Medical Biotechnologies ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCITONIN; CYSTEINE; DNA; LEVOTHYROXINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CODON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MULTIMODALITY CANCER THERAPY; ONCOGENE RET; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; TREATMENT OUTCOME;

EID: 0033304922     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.10.3522     Document Type: Article

References (26)

1. Genetic aspects of multiple endocrine neoplasia
2. The MEN 2 syndromes and the role of the ret proto-oncogene
3. Clinical characteritics distinguishing hereditary from sporadic medullary thyroid carcinoma treatment implications
4. Mutations of RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
5. The relationship between specific ret proto-oncogene mutations and desease phenotype in multiple endocrine neoplasia type 2: International ret mutation consortium analysis
6. Developmental expression of the RET proto-oncogene
7. Expression of the c-ret proto-oncogene during mouse embryogenesis
8. Cloning and expression of the ret protooncogene encoding a tyrosine kinase with two potential transmembrane domain
9. GDNF signalling through the Ret receptor tyrosine kinase
10. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-α a novel receptor for GDNF
11. Characterization of a multicomponent receptor for GDNF
12. Functional receptor for GDNF encoded by c-ret proto-oncogene
13. Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations
14. Germ-line mutations of MEN2A and MEN2B activate RET as a dominant trasforming gene by different molecular mechanisms
15. A mutation in the RET proto-oncogene in Hirschsprung's disease affects the tyrosine kinase activity associated with multiple endocrine neoplasia type 2A and 2B
16. Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A
17. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto-oncogene
18. A second generation linkage map of the human genome
19. Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression
20. A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A
21. Duplication of 9 base pair in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasie type 2A
22. Oncogene activation of the neu-encoded receptor protein by point mutation and deletion
23. Activation of Neu (ErbB-2) mediated by disulfide bond-induced dimerization reveals a receptor tyrosine kinase dimer interface
24. Treatment of pheochromocytoma: Changes in diagnosis and therapy
25. Overlapping expression of immunohistochemical markers and synaptophysin mRNA in pheochromocytomas and adrenocortical carcinomas. Implications for the differential diagnosis of adrenal gland tumors